Proctor & Gamble has agreed to sell its prescription drug business for $3.1 billion to the Irish pharmaceutical firm Warner Chilcott. School of Law Professor Kevin Outterson, an authority in pharma law and marketing, says the deal is evidence of further consolidation in the prescription drug industry.
“P&G evidently decided they couldn’t compete at at scale with only $2.3 billioin in annual revenues.”
Contact Kevin Outterson, 617-353-3130, mko@bu.edu
